We collect more than single-cell readouts from isolated experiments — we generate virtual patient profiles grounded in rich, longitudinal data across a broad spectrum of multi-omics and clinical assays.

We generate proprietary, patient-derived datasets collected across the timepoints that matter, giving machine learning the data it needs to truly impact drug development.

We learn representations of individual patients from multimodal longitudinal data across disease and treatment.

We embed DNA, methylation, transcriptomics, proteomics, imaging, and structured clinical data into one space, capturing the heterogeneity of patient biology.